All In MedTech

FDA Clearance Tracker · P880098-S011

MENICON SF-P (TM)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 6, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 6, 2000

Approved

Time to decision

85 days

Received Jun 13, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P880098-S011
Device name
MENICON SF-P (TM)
Applicant location
Wilmington, MA
Received
Jun 13, 2000
Decided
Sep 6, 2000
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Postapproval Study Protocol
Original approval
P880098

Device type

Device class
Class II
Regulation
21 CFR 886.5916
Specialty
Ophthalmology

Every decision under product code HQD

FDA's approval statement

As written in FDA's record.

APPROVAL OF PROCEDURES TO ADD LENS FINISHING LABORATORIES AS MANUFACTURERS AND DISTRIBUTORS OF CLASS III RGP EXTENDED WEAR CONTACT LENSES.

Source documents

Other decisions for Menicon Co, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.